Neurocrine Clinical Site

Irving, Texas 75062

0 studies enrolling now · 4 studies all time

What they study most

Tardive Dyskinesia (TD), Tourette Syndrome

Studies at this site

• Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome — Stopped early
• Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome — Completed
• Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia — Completed
• The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine — Completed